Scroll Down

The future of precision medicine starts here

Our mission is to develop targeted microbiome-based therapeutics and molecular diagnostic tools to prevent and treat diseases of high unmet medical needs

See Our Pipeline
 
 

Harnessing the power of microbiome-based therapeutics

Siolta Therapeutics is a clinical-stage biopharmaceutical company developing targeted microbiome-based therapeutics to prevent and treat diseases of high unmet medical need. By leveraging our proprietary Precision Symbiotics Platform™ and Live Biotherapeutics Products (LBPs) GMP-manufacturing capabilities, we are rapidly expanding our product pipeline across multiple indications with multiple programs in preclinical and clinical-stage development.

Our Proprietary Platform